Journals / Molecular Imaging and Radionuclide Therapy / 2019 / Cilt: 28 - Sayı: 3

Solitary Pulmonary Nodule: Morphological Effects on Metabolic Activity Assessment

Soliter Pulmoner Nodül: Metabolik Aktivite Değerlendirmesinde Morfolojik Etkiler

Pages
112–119
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a significant difference between SPNs

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We aimed to evaluate the effects of morphological characteristics of the solitary pulmonary nodules (SPN) on metabolic activityassessment.
📊
Key Findings & Data:To the best of our knowledge, this is the first study to compare the volumetric metabolic activity parameters according to themorphologic parameters of the nodules.Methods: In this retrospective study, 18F-FDG positron emission tomography and computed tomography scans performed between 2011 and2018 were evaluated by a nuclear and diagnostic radiologist.
💡
Conclusion & Impact:There was a significant difference between SPNs
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: We aimed to evaluate the effects of morphological characteristics of the solitary pulmonary nodules (SPN) on metabolic activityassessment. To the best of our knowledge, this is the first study to compare the volumetric metabolic activity parameters according to themorphologic parameters of the nodules.Methods: In this retrospective study, 18F-FDG positron emission tomography and computed tomography scans performed between 2011 and2018 were evaluated by a nuclear and diagnostic radiologist. One hundred thirteen patients with SPNs with biopsy-proven diagnosis wereincluded. SPNs were classified as solid, partially solid (PS), and ground glass opacity (GGO).Results: SPN diameter, SUVmax, metabolic tumor volume (MTV), total lesion glycolysis (TLG), and density were significantly higher in the malignantgroup. SUVmax, MTV, TLG increased in direct proportion to the diameter. There was no a significant difference between GGO, PS, and solid nodulesin terms of SUVmax values. MTV and TLG values increased in parallel with the density of the nodules, but this increase was only significant in themalignant group. There was a significant difference between SPNs

Özet

Amaç: Soliter pulmoner nodüllerin (SPN) morfolojik özelliklerinin metabolik aktivite değerlendirmesi üzerindeki etkilerini değerlendirmeyi amaçladık. Bildiğimiz kadarıyla, volümetrik metabolik aktivite parametrelerini nodüllerin morfolojik parametrelerine göre karşılaştıran ilk çalışma budur. Yöntem: 2011 ve 2018 yılları arasında yapılan 18F-FDG pozitron emisyon tomografisi ve bilgisayarlı tomografi taramaları, bir nükleer tıp uzmanı ve radyoloji uzmanı tarafından retrospektif olarak değerlendirildi. Biyopsi ile kanıtlanmış tanısı olan 113 SPN hastası dahil edildi. SPN’ler solid, kısmi solid (PS) ve buzlu cam opasitesi (GGO) olarak sınıflandırıldı. Bulgular: SPN çapı, SUVmaks, metabolik tümör hacmi (MTV), toplam lezyon glikoliz (TLG) ve dansite malign grupta anlamlı olarak yüksek bulundu. SUVmaks, MTV ve TLG değerleri çap ile doğru orantılı olarak arttı. GGO, PS ve solid nodüller arasında SUVmaks değerleri arasında anlamlı bir fark yoktu. MTV, TLG değerleri nodüllerin yoğunluğu ile paralel olarak arttı; ancak sadece malign grupta anlamlı fark bulundu. 2 cm’den küçük grupta MTV için anlamlı fark varken SUVmaks için yoktu. ROC eğrisi ile belirlenen kesme değerinin SUVmaks için 4,39, MTV için 7,33 mL, TLG için 31,88 g olduğu bulundu. Solid ve subsolid nodüllerin SUVmaks için cut-off değeri birbirine yakındı, ancak MTV, TLG için cut-off değer solid nodüllerde daha yüksekti.

🔖

Cite This Article

ERDOGAN, M., SENGUL, S. S., EVRIMLER, Ş., AYDIN, H., KARAIBRAHIMOGLU, A. (2022). Solitary Pulmonary Nodule: Morphological Effects on Metabolic Activity Assessment. Molecular Imaging and Radionuclide Therapy, Cilt: 28 - Sayı: 3, 112–119. https://ajindex.com/articles/653255

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Tuddenham WJ. Glossary of terms for thoracic radiology: recommendations of the Nomenclature Committee of the Fleischner Society. AJR Am J Roentgenol 1984;143:509-517
  2. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003;348:2535-2542
  3. Midthun DE, Swensen SJj, Jett JR, editors. Approach to the solitary pulmonary nodule. Mayo Clin Proc 1993;68:378-385
  4. Gohagan J, Marcus P, Fagerstrom R, Pinsky P, Kramer B, Prorok P; Writing Committee, Lung Screening Study Research Group. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest 2004;126:114-121
  5. Swensen SJ, Jett JR, Hartman TE, Midthun DE, Sloan JA, Sykes AM, Aughenbaugh GL, Clemens MA. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003;226:756-761
  6. Lee HY, Lee KS. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. J Thorac Imaging 2011;26:106-118
  7. Naidich DP, Bankier AA, MacMahon H, Schaefer-Prokop CM, Pistolesi M, Goo JM, Macchiarini P, Crapo JD, Herold CJ, Austin JH, Travis WD. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013;266:304-317
  8. Sim YT, Poon FW. Imaging of solitary pulmonary nodule-a clinical review. Quant Imaging Med Surg 2013;3:316-326
  9. Herder GJ, van Tinteren H, Golding RP, Kostense PJ, Comans EF, Smit EF, Hoekstra OS. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18 F-fluorodeoxyglucose positron emission tomography. Chest 2005;128:2490-2496
  10. Grgic A, Yüksel Y, Gröschel A, Schäfers H-J, Sybrecht GW, Kirsch CM, Hellwig D. Risk stratification of solitary pulmonary nodules by means of PET using 18 F-fluorodeoxyglucose and SUV quantification. Eur J Nucl Med Mol Imaging 2010;37:1087-1094
  11. Gould MK, Fletcher J, Iannettoni MD, Lynch WR, Midthun DE, Naidich DP, Ost DE; American College of Chest Physicians. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines. Chest 2007;132:108-130
  12. Divisi D, Barone M, Bertolaccini L, Rocco G, Solli P, Crisci R; Italian VATS Groupl. Standardized uptake value and radiological density attenuation as predictive and prognostic factors in patients with solitary pulmonary nodules: our experience on 1,592 patie